-
-
Call more information
660-596-2224 -
Authors: Sam A F, Shankar S, Nandakumar K, et al. Cureus 17(1): e77474. January 15, 2025 Abstract Background: Central venous catheters (CVCs) are the choice of venous access if patients require vasoactive drugs or multiple infusions but are not free of adverse effects. They should be removed when deemed unnecessary. In cases of difficult venous […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review Private equity has had an increased presence in the anesthesia industry, as reimbursement declines and staffing shortages push more anesthesia practices toward consolidation. According to an April 2022 study published in JAMA, anesthesia prices increased an average of 26% when anesthesia companies, backed by private-equity investors, took over HOPDs or […]
Read MoreAuthors: Ayaz F, Arafah O, Alshibi L, et al. Cureus 17(1): e77586. January 17, 2025 Abstract Local anesthetic systemic toxicity (LAST) is a rare but serious complication of regional anesthesia, particularly in neonates and infants due to their immature hepatic metabolism, reduced protein-binding capacity, and increased vascular absorption. We report the case of a two-month-old […]
Read MoreAuthors: Ramalingam Y, PM A, Nagalingam L, et al. Cureus 17(1): e77640. January 18, 2025 Background Clear communication is vital in anesthesiology to ensure patient safety and deliver high-quality care. Communication errors remain a significant cause of medical errors worldwide. The Modified Kalamazoo Consensus Statement Checklist (MKCSC) offers a structured approach to assessing communication skills. […]
Read MoreAuthors: Liang W, Nguyen D, Anche G, et al. Cureus 17(1): e77666. January 19, 2025 Abstract Sugammadex, a novel agent for reversing neuromuscular blockade, has become the preferred method for reversal over the combination of neostigmine and glycopyrrolate due to its lower risk of adverse effects and high efficacy in reversing paralytic agents. Its primary […]
Read More